Who is sponsoring NCT03383588?

NCT03383588 is sponsored by Montefiore Medical Center.

What condition does NCT03383588 study?

NCT03383588 studies Pain, Referred.

What drugs are being tested in NCT03383588?

Interventions: Bupivacaine, Morphine, Fentanyl, Epinephrine, Saline solution.

What is the status of NCT03383588?

NCT03383588 is currently TERMINATED.

Last reviewed 2020-01-13 · How we verify

Subcutaneous Bupivacaine Decrease Post-op Pain in Patients Undergoing C-Section

NCT03383588 PHASE2 TERMINATED Results posted

The purpose of this study is to determine if giving an injection of numbing medication at the incision at the end of cesarean will help control pain AFTER cesarean delivery. This study seeks to assess pain relief with incisional infiltration of local anesthetic during cesareans performed under spinal anesthesia also using intrathecal opioids. Participants will receive the usual regimen of pain medication in spinal anesthesia. At the end of the cesarean delivery, while the participants are still under the spinal medication, participants will receive an injection, at the incision, either numbing medication (with or without epinephrine) or sterile saline. After the cesarean delivery, participants will receive, by mouth, commonly prescribed pain medications - these medications are oxycodone (an opioid/ narcotic), acetaminophen (or more commonly known as Tylenol), and ibuprofen.

Details

Lead sponsor	Montefiore Medical Center
Phase	PHASE2
Status	TERMINATED
Enrolment	26
Start date	Thu Jul 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Dec 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Pain, Referred

Interventions

Bupivacaine
Morphine
Fentanyl
Epinephrine
Saline solution

Countries

United States